Crocs, Inc. - Common Stock (CROX)
86.56
+2.75 (3.28%)
NASDAQ · Last Trade: Aug 23rd, 1:06 PM EDT

Berkshire Hathaway bought $1.6 billion of United Health stock in Q2. Inflation may be ticking higher after all.
Via The Motley Fool · August 22, 2025
A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested that with inflation risks moderating and unemployment remaining low, the Federal Reserve might consider a shift in its monetary policy stance, including potential interest rate cuts. This outlook eased market concerns about prolonged high interest rates and their impact on economic growth. The prospect of lower borrowing costs bolstered investor confidence, particularly in sectors that have lagged, leading to a broad rally across the market.
Via StockStory · August 22, 2025
Crocs CFO Flags Wholesale Headwinds, Predicts Dip For Core Brand In Q3: Retail Smells Bigger Opportunity In International Growthstocktwits.com
Via Stocktwits · August 7, 2025
CROX stock appears undervalued with a low P/E ratio, high profitability, and strong financial health, making it a compelling pick for value investors seeking solid fundamentals.
Via Chartmill · August 20, 2025
Motley Fool Money checks in on some stock market news.
Via The Motley Fool · August 18, 2025
Rock-bottom prices don't always mean rock-bottom businesses.
The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Via StockStory · August 15, 2025
Via Benzinga · August 14, 2025
Footwear company Crocs (NASDAQ:CROX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.4% year on year to $1.15 billion. On the other hand, next quarter’s revenue guidance of $956 million was less impressive, coming in 10.7% below analysts’ estimates. Its non-GAAP profit of $4.23 per share was 5.3% above analysts’ consensus estimates.
Via StockStory · August 12, 2025
Crocs beat Q2 earnings expectations but lowered Q3 guidance as analysts cut price targets amid macro pressure and a softer North America outlook.
Via Benzinga · August 8, 2025
Via Benzinga · August 8, 2025
Wall Street has experienced a broadly positive day, marked by a resilient rally that has added over $1 trillion in market value. This surge in investor confidence is primarily driven by a confluence of strong corporate earnings, sustained momentum in the technology sector, and a perceived easing of anxieties related
Via MarketMinute · August 8, 2025
Via Benzinga · August 8, 2025
Footwear company Crocs (NASDAQ:CROX) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.4% year on year to $1.15 billion. On the other hand, next quarter’s revenue guidance of $956 million was less impressive, coming in 10.7% below analysts’ estimates. Its non-GAAP profit of $4.23 per share was 5.3% above analysts’ consensus estimates.
Via StockStory · August 7, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · August 7, 2025
Via Benzinga · August 7, 2025
Via Benzinga · August 7, 2025
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · August 7, 2025
Crocs shares are trading lower Thursday after the company said it expects third quarter revenue to be down approximately 9% to 11%.
Via Benzinga · August 7, 2025
Let's have a look at the gap up and gap down stocks in today's session.
Via Chartmill · August 7, 2025
Crocs Q2 2025 earnings show mixed results: EPS beats estimates at $4.23, but revenue misses at $1.149B, sparking a 14.8% pre-market drop.
Via Chartmill · August 7, 2025